retatrutide clinical trials countries Preventing obesity-related cancer with the revolution in obesity management: the challenges of undertaking a trial and potential solutions This weight-loss drug hasn't been

It is the story of a gut hormone glucagon-like peptide-1, or GLP-1 discovered in a Copenhagen laboratory in the 1980s, that turns out to sit at the centre of a wider physiological network linking the small intestine to the brain, the immune system, the cardiovascular system, and the metabolic regulation of nearly every major organ

CagriSema is highly effective, but tirzepatide (Zepbound) edges it out in a direct comparison

The link between metabolic syndrome and alzheimer disease: A mutual relationship and long rigorous investigation

NICE guidance (NG28) does not differentiate between agents based on anti-inflammatory properties

The Peptide Craze I review what we know about 15 different injectable peptides being used without FDA approval or off-label, and NAD+ GLP-1s remain the rare rigorously studied exception

Pipe smokers more frequently display pigmentation of the commissures (corners of the mouth) and buccal mucosae